EW
Edwards Lifesciences Corporation
NYSE · USHealthcareMedical - Devices
$85.00-0.85%
Price as of Jul 20, 2026
EW profitability
Edwards Lifesciences Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 78.0%
- EBITDA margin
- 22.5%
- EBIT margin
- 27.6%
- Net margin
- 17.3%
- Free cash flow margin
- 17.3%
Returns
- Return on equity
- 10.6%
- Return on assets
- 8.2%
- Return on invested capital
- 15.8%
- Asset turnover
- 0.47x
Cash efficiency
- Cash from operations
- $1.4B
- Cash per share
- $6.38
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.